Literature DB >> 8667464

Relative toxicity of beta blockers in overdose.

D M Reith1, A H Dawson, D Epid, I M Whyte, N A Buckley, G P Sayer.   

Abstract

OBJECTIVE: To compare the toxicity of beta blockers in overdose and to identify clinical features predictive of serious toxicity.
DESIGN: Comparison of clinical data collected prospectively on a relational database of subjects presenting to hospital with self-poisoning, coroner's data and prescription data.
SETTING: Newcastle and Lake Macquarie, Australia, 1987-1995. MAIN OUTCOME MEASURES: Death, seizure, cardiovascular collapse, hypoglycemia, coma and respiratory depression.
SUBJECTS: Fifty-eight self-poisonings with beta blockers and two deaths investigated by the coroner with evidence of propranolol poisoning.
RESULTS: All patients who developed toxicity did so within six hours of ingestion. The use of ipecac was temporally associated with cardiorespiratory arrest in one patient. Propranolol was the only beta blocker associated with seizure; of those who ingested more than 2 g of propranolol, two thirds had a seizure. There was a significant association between a QRS duration of > 100 ms and risk of seizures. Propranolol was over represented in beta blocker poisoning when prescription data were also examined. Propranolol was the only beta blocker associated with death. Propranolol was taken by a younger age group.
CONCLUSIONS: Propranolol should be avoided in patients at risk of self-poisoning. Propranolol poisonings should be observed closely for the first six hours post ingestion. Syrup of ipecac should not be used to decontaminate the gastrointestinal tract after beta blocker overdose.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8667464     DOI: 10.3109/15563659609013789

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  13 in total

1.  Radiation preparation of L-arginine/acrylic acid hydrogel matrix patch for transdermal delivery of propranolol HCl in hypertensive rats.

Authors:  Rasha R Radwan; Heba A Mohamed; H E Ali; Ghada A Mahmoud
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

2.  Acute fatal poisoning with pilsicainide and atenolol.

Authors:  W Hikiji; K Kudo; N Nishida; T Ishida; Y Usumoto; A Tsuji; N Ikeda
Journal:  Int J Legal Med       Date:  2008-07-19       Impact factor: 2.686

3.  The use of high-dose insulin-glucose euglycemia in beta-blocker overdose: a case report.

Authors:  Colin Page; L Peter Hacket; Geoffrey K Isbister
Journal:  J Med Toxicol       Date:  2009-09

4.  Management of a mixed overdose of calcium channel blockers, β-blockers and statins.

Authors:  Reena Thakrar; Rob Shulman; Geoff Bellingan; Mervyn Singer
Journal:  BMJ Case Rep       Date:  2014-06-06

5.  Too many pills to swallow: A case of a mixed overdose.

Authors:  Louise Emily Hopkins; Jonathan Sunkersing; Andrew Jacques
Journal:  J Intensive Care Soc       Date:  2017-02-20

6.  The role of fat emulsion therapy in a rodent model of propranolol toxicity: a preliminary study.

Authors:  Grant Cave; Martyn G Harvey; Craig D Castle
Journal:  J Med Toxicol       Date:  2006-03

7.  Intralipid infusion ameliorates propranolol-induced hypotension in rabbits.

Authors:  Martyn G Harvey; Grant R Cave
Journal:  J Med Toxicol       Date:  2008-06

8.  Cardiovascular toxicity due to metoprolol poisoning in a patient with coronary artery disease.

Authors:  Pinar Unverir; Hakan Topacoglu; Selim Bozkurt; Firat Kaynak
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

9.  Insulin versus Lipid Emulsion in a Rabbit Model of Severe Propranolol Toxicity: A Pilot Study.

Authors:  Martyn Harvey; Grant Cave; Daniel Lahner; Jan Desmet; Gaynor Prince; Gary Hopgood
Journal:  Crit Care Res Pract       Date:  2011-03-31

10.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.